![Shubh Goel: Bold and unexpected collaborations can push cancer care boundaries](https://oncodaily.com/pub/uploads/2025/02/image-16-e1738779572977.png)
Shubh G./LinkedIn
Feb 6, 2025, 15:19
Shubh Goel: Bold and unexpected collaborations can push cancer care boundaries
Shubh Goel, Vice President, Global Franchise Head for BiSpecifics at AstraZeneca, shared a post on LinkedIn:
“Eliminating cancer as a cause of death is a goal shared across the globe – but no one country, company or stakeholder can do it alone.
Bold and unexpected collaborations can push cancer care boundaries, yielding far-reaching outcomes that benefit patients, health systems and society.
Learn more in this article by my colleague, David Fredrickson, EVP, Oncology Hematology Business Unit.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 6, 2025, 15:13
Feb 6, 2025, 15:12
Feb 6, 2025, 15:11